| 113.82 1.79 (1.6%) | 06-08 15:59 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 133.81 |
1-year : | 156.29 |
| Resists | First : | 114.56 |
Second : | 133.81 |
| Pivot price | 108.96 |
|||
| Supports | First : | 104.79 |
Second : | 98.76 |
| MAs | MA(5) : | 112.14 |
MA(20) : | 107 |
| MA(100) : | 101.1 |
MA(250) : | 91.61 |
|
| MACD | MACD : | 2.6 |
Signal : | 2.1 |
| %K %D | K(14,3) : | 94.7 |
D(3) : | 93.2 |
| RSI | RSI(14): 67.9 |
|||
| 52-week | High : | 120.9 | Low : | 75.13 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ XTN ] has closed below upper band by 20.3%. Bollinger Bands are 18.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 114.67 - 115.48 | 115.48 - 116.11 |
| Low: | 110.93 - 111.79 | 111.79 - 112.46 |
| Close: | 112.7 - 114.03 | 114.03 - 115.06 |
The State Street SPDR S&P Transportation ETF (XTN) aims to mirror the investment performance of the S&P Transportation Select Industry Index, prior to accounting for fees and expenses. This fund offers comprehensive access to the diverse transportation sector, spanning a wide array of specialized areas. These include air freight and logistics, airport services, cargo and passenger ground transportation, highways and rail tracks, marine shipping and ports, and passenger airlines. XTN achieves this by tracking a modified equally-weighted index, which ensures a balanced allocation across companies of varying market capitalizations—from established large-cap leaders to emerging mid and small-cap innovators—thus mitigating concentration risk. This design enables investors to implement more precise strategic or tactical investment positions within the transportation industry, providing a more granular approach than broader, generalized sector funds.
Sun, 07 Jun 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
Fri, 05 Jun 2026
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) be on your investing radar? - MSN
Fri, 05 Jun 2026
Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) be on your investing radar? - MSN
Thu, 04 Jun 2026
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
Wed, 03 Jun 2026
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Tue, 02 Jun 2026
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Global
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |